Home › Duchenne Muscular Dystrophy › Texas
Duchenne Muscular Dystrophy clinical trials in Texas
5 studies for Duchenne Muscular Dystrophy are looking for participants at sites in Texas.
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Neurology Rare Disease Center, Flower Mound
RecruitingPhase 3
Ages 7 to 11 · Men · Updated Sep 28, 2026 · NCT07160634Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
- The University of Texas Health Science Center at San Antonio, San Antonio
RecruitingObservational study
Ages 2 and older · Men · Updated Sep 24, 2026 · NCT06564974A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
- Neurology Rare Disease Center, Flower Mound
RecruitingPhase 1
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT04626674Once Weekly Infant Corticosteroid Trial for DMD
- University of Texas Southwestern, Dallas
RecruitingPhase 4
1 Month – 30 Months · Men · Updated Aug 14, 2026 · NCT05412394Duchenne Electronic Health Record Study
- UT Southwestern Medical Center, Dallas
RecruitingObservational study
All ages · All sexes · Updated May 27, 2026 · NCT07609394From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.